IN2012DN03818A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03818A
IN2012DN03818A IN3818DEN2012A IN2012DN03818A IN 2012DN03818 A IN2012DN03818 A IN 2012DN03818A IN 3818DEN2012 A IN3818DEN2012 A IN 3818DEN2012A IN 2012DN03818 A IN2012DN03818 A IN 2012DN03818A
Authority
IN
India
Application number
Inventor
Irene Erdelmeier
Original Assignee
Tetrahedron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tetrahedron filed Critical Tetrahedron
Publication of IN2012DN03818A publication Critical patent/IN2012DN03818A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00Racemisation; Complete or partial inversion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
IN3818DEN2012 2009-10-06 2012-05-01 IN2012DN03818A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0956962A FR2950889B1 (en) 2009-10-06 2009-10-06 PROCESS FOR SYNTHESIZING ERGOTHIONEIN AND THE LIKE
PCT/EP2010/064950 WO2011042480A1 (en) 2009-10-06 2010-10-06 Method for the synthesis of ergothioneine and the like

Publications (1)

Publication Number Publication Date
IN2012DN03818A true IN2012DN03818A (en) 2015-08-28

Family

ID=41650166

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3818DEN2012 IN2012DN03818A (en) 2009-10-06 2012-05-01

Country Status (13)

Country Link
US (1) US8399500B2 (en)
EP (1) EP2486020B1 (en)
JP (2) JP5813647B2 (en)
KR (1) KR101832396B1 (en)
CN (1) CN102686568B (en)
AU (1) AU2010305399B2 (en)
BR (1) BR112012007869B1 (en)
CA (1) CA2776836C (en)
ES (1) ES2646331T3 (en)
FR (1) FR2950889B1 (en)
IN (1) IN2012DN03818A (en)
RU (1) RU2550202C2 (en)
WO (1) WO2011042480A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2950890B1 (en) 2009-10-06 2011-12-30 Tetrahedron PROCESS FOR SYNTHESIZING 2-THIOHISTIDINE AND THE LIKE
US10167490B2 (en) 2012-12-21 2019-01-01 Ergo Health Llc Ergothioneine production through metabolic engineering
CA2975238C (en) 2014-04-29 2021-05-11 Conagen Inc. Microbial ergothioneine biosynthesis
FR3021655B1 (en) 2014-05-30 2016-07-08 Tetrahedron NOVEL 5-ACYLSULFANYL-HISTIDINE COMPOUNDS AS PRECURSORS OF THE CORRESPONDING 5-SULFANYLHISTIDINS AND THEIR DISULFIDE
GB201416678D0 (en) * 2014-09-22 2014-11-05 Univ Cape Town Process For Synthesizing Ergothioneine And Its Intermediates
EP3268354B1 (en) * 2015-03-13 2020-05-06 Mironova Innovations, LLC Nalpha, nalpha, nalpha-trialkyl histidine derivatives useful for the preparation of ergothioneine compounds
KR20220031065A (en) 2019-07-10 2022-03-11 가부시끼가이샤 구레하 Plant growth regulator and method for promoting plant growth
KR20220081067A (en) 2020-12-08 2022-06-15 코오롱인더스트리 주식회사 Recombinant yeast with enhanced ergothioneine productivity and method for producing ergothioneine using the same
AU2021457422A1 (en) * 2021-07-28 2024-02-15 Nanjing Nutrabuilding Bio-Tech Co., Ltd. L-ergothioneine and therapeutic uses thereof
US11491141B1 (en) 2022-01-06 2022-11-08 Nanjing Nutrabuilding Bio-Tech Co., Ltd. Methods of treating glutathione deficiencies and deficiencies in glutathione synthetase activity
WO2023201707A1 (en) * 2022-04-22 2023-10-26 Nanjing Nutrabuilding Bio-Tech Co., Ltd. Process for chemical synthesis of ergothioneine and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707087B1 (en) 1993-06-28 1995-10-13 Bioxytech New process for the preparation of ergothionein.
GB9811427D0 (en) * 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
CN101052638B (en) * 2004-09-24 2011-01-19 阿勒根公司 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
US7115748B2 (en) * 2004-12-07 2006-10-03 Allergan, Inc. Method of making imidazole-2-thiones
US7767826B2 (en) * 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
JP2009161498A (en) * 2008-01-10 2009-07-23 Univ Nagoya Method for producing ergothioneine

Also Published As

Publication number Publication date
EP2486020B1 (en) 2017-08-16
US20120136159A1 (en) 2012-05-31
CA2776836C (en) 2019-01-15
JP2013506706A (en) 2013-02-28
ES2646331T3 (en) 2017-12-13
AU2010305399A1 (en) 2012-05-17
KR101832396B1 (en) 2018-02-26
FR2950889A1 (en) 2011-04-08
US8399500B2 (en) 2013-03-19
BR112012007869A2 (en) 2015-09-22
RU2550202C2 (en) 2015-05-10
JP5813647B2 (en) 2015-11-17
CN102686568A (en) 2012-09-19
JP2016006099A (en) 2016-01-14
RU2012117978A (en) 2013-11-20
CN102686568B (en) 2015-03-18
FR2950889B1 (en) 2011-11-18
BR112012007869B1 (en) 2021-10-13
KR20120091187A (en) 2012-08-17
WO2011042480A1 (en) 2011-04-14
AU2010305399B2 (en) 2014-06-12
CA2776836A1 (en) 2011-04-14
EP2486020A1 (en) 2012-08-15

Similar Documents

Publication Publication Date Title
BR112012008267A2 (en)
BR112012008195A2 (en)
BRPI0924307A2 (en)
BR112012003080A2 (en)
BR122021004633A2 (en)
BR122017024704A2 (en)
BR112012012487A2 (en)
BR112012003853A2 (en)
BR112012009797A2 (en)
BR112012012080A2 (en)
BR112012009446A2 (en)
BR112012009703A2 (en)
BR112012010357A2 (en)
BR112012007656A2 (en)
BR122019005883A2 (en)
BR112012002627A2 (en)
BR112012014856A2 (en)
BRPI0924534A2 (en)
BR112012007654A2 (en)
BR112012007672A2 (en)
BR112012005951A2 (en)
BR112012000156A2 (en)
BRPI0924617A2 (en)
BR122017013721A2 (en)
BR112012009404A2 (en)